Evidence map›Paper›PMID 41331741›Full record

ArticleEuropean heart journal. Quality of care & clinical outcomes2026

Association between quality of care indicators and clinical outcomes in patients undergoing transcatheter aortic valve implantation: insights from SWEDEHEART.

Konrad Nilsson, Stefan James, Jenny Backes, Matthias Götberg, Henrik Hagström, Gorav Batra

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in European heart journal. Quality of care & clinical outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Konrad NilssonCardiology, Department of Medical Sciences, Uppsala University, Akademiska sjukhuset ing. 40, SE-751 85 Uppsala, Sweden.ORCID 0000-0002-8329-5072
Stefan JamesCardiology, Department of Medical Sciences, Uppsala University, Akademiska sjukhuset ing. 40, SE-751 85 Uppsala, Sweden.ORCID 0000-0003-4413-9736
Jenny BackesSchool of Medical Sciences, Faculty of Medicine and Health, Örebro University, Campus USÖ, SE-701 82 Örebro, Sweden.ORCID 0009-0008-3439-178X
Matthias GötbergCardiology Unit, Department of Clinical Sciences Lund, Lund University, Sölvegatan 19, SE-223 62 Lund, Sweden.
Henrik HagströmDepartment of Public Health and Clinical Medicine, Umeå University, SE-901 87 Umeå, Sweden.ORCID 0000-0003-1182-4462
Gorav BatraCardiology, Department of Medical Sciences, Uppsala University, Akademiska sjukhuset ing. 40, SE-751 85 Uppsala, Sweden.ORCID 0000-0002-2480-9547

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe European Society of Cardiology (ESC) has developed quality indicators (QIs) specifically for evaluating the care and outcomes for patients undergoing transcatheter aortic valve implantation (TAVI). The aim of this study was to evaluate TAVI care in all patients undergoing such procedures in Sweden using the ESC 2023 QIs for TAVI. METHODS AND

resultsWe used the Swedish Transcatheter Cardiac Intervention Registry to identify all TAVI procedures performed in Swedish centres (n = 8) between 2008 and 2021. 8524 patients (median 82 years, 52.8% male) were included. In total, 24 (88.8%) of the 27 QIs could be captured from the available registry data. The attainment levels were generally high [median 97.8%, interquartile range (IQR) 91.3-100%] with small variations in attainment levels between centres. The greatest variations were observed in the QIs related to patients undergoing TAVI through transfemoral route (median 90.3%, IQR 85.6-96.9%), and in the proportion undergoing transfemoral TAVI without general anaesthesia (median 87.6%, IQR 57.1-94.4%). In total, 80% of the QIs were associated with 1-year all-cause mortality, and 85% with 1-year cardiovascular mortality. The QIs with greatest impact on 1-year mortality were the absence of coronary obstruction (adjusted HR 0.12; 95% CI 0.07-0.22), in-hospital stroke (adjusted HR 0.25; 95% CI 0.18-0.33) and no new dialysis (adjusted HR 0.25; 95% CI 0.15-0.41).

conclusionIn this study, the majority of the QIs were associated with both all-cause and cardiovascular mortality. Hence, the ESC 2023 QIs for TAVI may serve as a valuable tool for evaluating TAVI care, benchmarking performance, and improving patient outcomes.

Indexed as

Aortic Valve StenosisQuality Indicators, Health CareRegistriesTranscatheter Aortic Valve ReplacementAgedAged, 80 and overFemaleHumansMalePostoperative ComplicationsRetrospective StudiesSwedenTreatment OutcomeCardiovascular outcomesImplementationMortalityQuality indicatorsQuality of careTranscatheter aortic valve implantation

Identifiers

PMID41331741
PMCPMC13124748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.